KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Copart (CPRT) Other financing activities (2016 - 2026)

On a quarterly basis, Other financing activities rose 10.45% to $9.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was $37.0 million, a 99.02% increase, with the full-year FY2022 number at $1.2 million, changed N/A from a year prior.

Copart (CPRT) has 11 years of Other financing activities data on record, last reported at $9.7 million in Q1 2026.

  • Other financing activities reached $9.7 million in Q1 2026 per CPRT's latest filing, up from $8.7 million in the prior quarter.
  • Over the last five years, Other financing activities for CPRT hit a ceiling of $9.8 million in Q4 2024 and a floor of $8.7 million in Q4 2025.
  • A 3-year average of $9.3 million and a median of $9.2 million in 2025 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: decreased 11.14% in 2025, then rose 10.45% in 2026.
  • Tracing CPRT's Other financing activities over 3 years: stood at $9.8 million in 2024, then dropped by 11.14% to $8.7 million in 2025, then rose by 10.46% to $9.7 million in 2026.
  • Business Quant data shows Other financing activities for CPRT at $9.7 million in Q1 2026, $8.7 million in Q4 2025, and $8.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 9.66 Mn
Jan 31, 2026 9.66 Mn
Oct 31, 2025 8.75 Mn
Oct 31, 2025 8.75 Mn
Jan 31, 2025 8.75 Mn
Jan 31, 2025 8.75 Mn
Oct 31, 2024 9.85 Mn
Oct 31, 2024 9.85 Mn
Jul 31, 2016 1.01 Mn
Jul 31, 2016 1.01 Mn